Comparative Study of Cryotherapy versus Trichloroacetic Acid Chemical Peels in the Treatment of Actinic Keratosis
DOI:
https://doi.org/10.25079/ukhjse.v3n1y2019.pp59-63Keywords:
Actinic keratosis, Cryotherapy, Squamous cell carcinoma, Trichlororacetic acidAbstract
Actinic keratosis is cutaneous neoplasm which is including of expansion of cytologically unusual epidermal keratinocytes that grow in response to prolonged exposure to ultraviolet radiation. Since some percentage of actinic keratosis will develop to non-melanoma skin cancers, their treatment is recommended. The study aimed to evaluate the clinical effectiveness of cryotherapy in comparison to topical 25% trichloroacetic acid chemical peels in the treatment of actinic keratosis. A comparative therapeutic study was conducted on forty four patients with actinic keratosis who attended Erbil dermatology teaching center in Erbil city of Kurdistan Region-Iraq. Patients were randomly allocated into two groups: cryotherapy treatment with liquid nitrogen every two weeks and trichloroacetic acid peels every two weeks and the response was controlled on follow up by taking photos. Patient’s age ranged from 40 to 80 years, they were analyzed for 24 weeks. Good response rate was seen in 72.8% of cryotherapy group and 40.9% of trichloroacetic acid group and this was statistically significant (p=0.02). Cryotherapy was more effective than trichloroacetic acid in the treatment of actinic keratosis.
Downloads
References
Duncan, K. O., Geisse, J. K. & Leffell, D. J. (2011). Epithelial precancerous lesion. In: Goldsmith, L. A., Katz, S. I., Gilchrest, B. A., Paller, A. S., Leffcll, D. J. & Wolf, K., (Eds). Fitzpatrick’s Dermatology in General Medicine. 8th ed. New York: Mac Graw-Hill. pp. 661-170.
Fitzpatrick, J. E. & Morelli, J. G. (2011). Dermatology Secrets Plus. 4th ed. Philadelphia, PA: Elsevier, Mosby.
Girish, G., Vishal, M. & Lear, J. L. (2016). Squamous cell carcinoma and its precursors. In: Christopher, G., Breathnuch, S. M. & Cox, N., (Eds). Rooks Text Book of Dermatology. 9th ed. Oxford: Wiley.
James, W. D., Burger, T. G. & Elston, D. M. (2016). Andrew’s Disease of the Skin: Clinical Dermatology.12th ed. Philadelphia, PA: Elsevier. p. 634.
Khunger, N. & Iadvl, T. F. (2008). Standard guidelines of care for chemical peels. Indian Journal of Dermatology, Venereology and Leprology, 74 Suppl 1, 5-12.
Kligman, A. M., Baker, T. J. & Gordon, H. L. (1985). Long-term histologic follow-up of phenol face peels. Plastic and Reconstructive Surgery, 75, 652-659.
Lugo-Janer, A., Lugo-Somolinos, A. & Sanchez, J. L. (2003). Comparison of trichloroacetic acid solution and cryosurgery in the treatment of solar lentigines. International Journal of Dermatology, 42(10), 829-831.
Monheit, G. D. & Kayal, J. D. (2003). Chemical peeling. In: Nouri, K. & Leal-Khouri, S., (Eds). Techniques of Dermatologic Surgery. St Louis: Elsevier. pp. 233-244.
Salasche, S. J. (2000). Epidemiology of actinic keratoses and squamous cell carcinoma. Journal of the American Academy of Dermatology, 42(1), 4-7.
Savant, S. S., (Eds). (2005). Superficial and medium depth chemical peeling. In: Textbook of Dermatosurgery and Cosmetology. 2nd ed. Mumbai: ASCAD. p. 177-195.
Thai, K. E., Fergin, P., Freeman, M., Vinciullo, C., Francis, D., Spelman, L., Murrell, D., Anderson, C., Weightman, W., Reid, C., Watson, A. & Foley, P. (2004). A prospective study of the use of cryosurgery for the treatment of actinic keratoses. International Journal of Dermatology, 43(9), 687-692.
The British Association of Dermatology. (2008). Cryotherapy. Patient Information Leaflet. Product. Available from: http://www.bad.org. uk/site/1192/Default.aspx. [Last accessed on 2018 Mar].
Uhlenhake, E. E. (2013). Optimal treatment of actinic keratoses. Clinical Interventions in Aging, 8, 29-35.
Vachiramon, V. & Thadanipon, K. (2011). Postinflammatory hypopigmentation. Clinical and Experimental Dermatology,
36(7), 708-714.
Zhang, N., Gong, K., Zhang, X., Yang, Y. & Na, Y. (2010). Extra mammary paget’s disease of scrotum-report of 25 cases and literature review. Urologic Oncology, 28(1), 28-33.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-ND 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).